We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Consumer advice and details of how to report problems with e-cigarettes with guidance on how to place an e-cigarette on the market in Great Britain and Northern Ireland, including the notification scheme.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Guidance on submitting an application for approval of a clinical trial that includes an in vitro diagnostic device
A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
You must get permission to export certain drugs and medicines.
This guidance clarifies the expectations on the application of the EU guidance on good pharmacovigilance practices (GVP)
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration into the UK market.
The eMIT provides information about prices and usage for generic drugs and pharmaceutical products.
A letter to community pharmacy contractors to set out the detail of the agreed funding arrangements for community pharmacy.
A digital platform designed to facilitate the reporting, monitoring, and management of medical device incidents.
Fees payable to the MHRA from 2025.
Information on comparator products used in studies supporting abridged marketing authorisation application.
Information about how the MHRA regulates medical devices in Northern Ireland and what legislation applies to manufacturers and suppliers.
How to register on the MHRA portal and use it to apply for and update marketing authorisations and make other applications.
Guidance on using non-investigational medicinal products in a clinical trial.
Detailed guidance on advertising and promoting medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).